Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL Read more about Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL
A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRX™ Anorectal Wand Read more about A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRX™ Anorectal Wand
Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies Read more about Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies
Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer Read more about Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer
Phase I/II Study of Avelumab in Pediatric Cancer Subjects Read more about Phase I/II Study of Avelumab in Pediatric Cancer Subjects
Collection and Storage of Tissue and Blood Samples From Patients With Cancer Read more about Collection and Storage of Tissue and Blood Samples From Patients With Cancer
Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer Read more about Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer
PD-1 Inhibition in Advanced Myeloproliferative Neoplasms Read more about PD-1 Inhibition in Advanced Myeloproliferative Neoplasms
ENTRATA: CB-839 With Everolimus vs. Placebo With Everolimus in Patients With Renal Cell Carcinoma (RCC) Read more about ENTRATA: CB-839 With Everolimus vs. Placebo With Everolimus in Patients With Renal Cell Carcinoma (RCC)
Pembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-05/ECHO-305-05) Read more about Pembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-05/ECHO-305-05)